Search
START domain-containing protein 10
go.drugbank.com/bio_entities/BE0021582TransporterHumansMay play metabolic roles in sperm maturation or fertilization (By similarity). Phospholipid transfer protein that preferentially selects lipid species containing a palmitoyl or stearoyl chain on the sn-1 and an unsaturated fatty acyl cha...
Polypeptides: START domain-containing protein 10Synonyms: StAR-related lipid transfer protein 10Hydroxyethyl Starch
go.drugbank.com/drugs/DB09106ApprovedInvestigationalHydroxyethyl starch (HES/HAES) is a nonionic starch derivative. Hydroxyethyl starches (HES) are synthetic colloids commonly used for fluid resuscitation to replace intravascular volume. HES is a general term and can be sub-classified acc...
Mixtures: Tetraspan Solution for Infusion 10%, Tetraspan 10% Solution for InfusionProducts: HAES-STERIL %10 500 ML SOLUSYON, BIOHES %10 INTRAVENOZ 500 ML SOLUSYON SETLI SISEEsomeprazole
go.drugbank.com/drugs/DB00736ApprovedInvestigationalEsomeprazole exerts its stomach acid-suppressing effects by preventing the final step in gastric acid production by covalently binding to sulfhydryl groups of cysteines found on the (H+, K+)-ATPase enzyme
Mixtures: OCAM PROTECT 15 MG, VONO 500 MG/20 MG DEĞİŞTİRİLMİŞ SALIMLI TABLET, 30 ADETCategories: Heterocyclic Compounds, 1-RingMebeverine
go.drugbank.com/drugs/DB12554ApprovedInvestigationalWithdrawnMebeverine has been investigated for the treatment of Irritable Bowel Syndrome and Post-cholecystectomy Gastrointestinal Spasms.
Products: DUSPATALIN LIKIT 10 MG/ML, 250 ML, DUSPATALIN 100 MG KAPLI TABLET, 50 ADETBCG vaccine
go.drugbank.com/drugs/DB12768ApprovedInvestigationalWithdrawnBCG vaccine has been investigated for the treatment of Neoplasms, Bladder Cancer, Neoplasms by Site, Urologic Diseases, and Urologic Neoplasms, among others.
Products: CALGEVAX-BCG 11.25 MG INTRAVEZIKAL ENJEKSIYON IÇIN LIYOFILIZE TOZ IÇEREN AMPUL, 10 ADET, BCG CULTURE SSI 30 MG 4 VIALRitonavir
go.drugbank.com/drugs/DB00503ApprovedInvestigationalgenotype 1a without cirrhosis or with compensated cirrhosis. … Any HCV/HIV-1 co-infected patients treated with ritonavir-containing combination therapies should also be on a suppressive antiretroviral drug regimen to reduce the risk of HIV-1 protease inhibitor drug
Mixtures: LOPIMUNE ® + RITONAVIR 10 MG - PELLETS EN CÁPSULAS ORALES, ALUVIA (100 MG/25 MG)Categories: Heterocyclic Compounds, 1-Ring, Experimental Unapproved Treatments for COVID-19Carglumic acid
go.drugbank.com/drugs/DB06775ApprovedInvestigationalCarglumic acid was approved by the U.S. Food and Drug Administration (FDA) on 18 March 2010.
Categories: Carbamoyl Phosphate Synthetase 1 Activator, Carbamoyl Phosphate Synthetase 1 ActivatorsProducts: PERLUGA 200 MG DAĞILABİLİR TABLET, 15 ADET, Glumacid 200 mg Dağılabilir Tablet, 15 ADETLixisenatide
go.drugbank.com/drugs/DB09265ApprovedInvestigationalIt is sold by Sanofi-Aventis under the brand name Adlyxin in the US[L763] and Lyxumia in the EU.[L764] Adlyxin recieved FDA approval July 28, 2016.[L763] … Lixisenatide is a glucagon-like peptide-1 (GLP-1) receptor agonist used in the treatment of type II diabetes mellitus (T2DM).
Mixtures: SOLIQUA® 10-40, SOLİQUA SOLOSTAR 100 U/ML + 50 MCG/ML SC ENJEKSİYONLUK ÇÖZELTİ İÇEREN KULLANIMA HAZIR KALEM, 5 KALEMCategories: Receptors, G-Protein-Coupled, Glucagon-like peptide-1 (GLP-1) analoguesRifaximin
go.drugbank.com/drugs/DB01220ApprovedInvestigationalIt is marketed under the brand name Xifaxan by Salix Pharmaceuticals. … It has multiple indications and is used in treatment of traveller's diarrhea caused by E. coli; reduction in risk of overt hepatic encephalopathy recurrence; as well as diarrhea-predominant irritable bowel
Synonyms: Rifamycin L 105Products: Colidimin 200 mg/10 ml - Granulat für orale Suspension, HEPAZEC 200 MG FILM TABLET, 12 ADETAzithromycin
go.drugbank.com/drugs/DB00207ApprovedInvestigationalIn March 2020, a small study was funded by the French government to investigate the treatment of COVID-19 with a combination of azithromycin and the anti-malaria drug [hydroxychloroquine]. … It was initially approved by the FDA in 1991 [A174175].
Categories: Experimental Unapproved Treatments for COVID-19Products: AZITHROMYCIN FOR INJECTION 500 MG/VIAL , 10 ML LYO VIAL, AZYDROP®15 MG/G